Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 2
MMP-9 Inhibition for Recalcitrant Wet Age-Related Macular Degeneration (AMD)
Wet (or neovascular) form of age-related macular degeneration (wAMD) is the most common cause of blindness in the Western world. Currently, anti-vascular endot…
Exudative Macular DegenerationWet Age-related Macular Degeneration
University of IowaNCT04504123
Phase 3
A Randomized, Partially Masked, Controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants With nAMD
ABBV-RGX-314 (also known as RGX-314 and surabgene lomparvovec (sura-vec)) is being developed as a novel one-time gene therapy for the treatment of neovascular …
AMDnAMDWet Age-related Macular Degeneration+3 more
AbbVieNCT05407636